BSEKimia Biosciences LtdMediumNeutral
Announced Sat, 18 Apr · 19:31 IST

Outcome of Board Meeting held on 18 April 2026 under regulation 30 of Sebi(Lodr) Regulations 2015 - Change in Management

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹37.40
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-1.1+2.4-1.8+0.3-4.1-2.4-1.6-12.6-10.9
Up moveDown movePending
AI summary

The Board meeting held on April 18, 2026 approved several management changes. Ms. Richa Gupta ceased as Independent Director effective April 14, 2026, after completing her maximum ten-year tenure as permitted under the Companies Act, 2013 - this is a routine regulatory requirement, not a resignation. Mr. Amulya Kumar Nayak was appointed as Additional Director (Non-Executive, Non-Independent) from April 18, 2026; he is a finance professional with over 32 years of experience in finance, accounts, and taxation, previously with companies like Punj Lloyd and Pepsi Foods. The Board also modified the appointment terms for Managing Director Mr. Sameer Goel to include retirement by rotation. Committee reconstitution was approved following these changes, with Mr. Nayak joining the Nomination & Remuneration Committee.

Likely market impact

These are routine governance changes following regulatory tenure limits and board composition adjustments. The replacement of a departing Independent Director with a seasoned finance professional maintains board continuity without raising red flags for investors.